Akèy › Enfeksyon COVID-19 ak Koronaviris
Etid klinik pou Enfeksyon COVID-19 ak Koronaviris ap rekrite nan Etazini
24 etid pou Enfeksyon COVID-19 ak Koronaviris ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC7 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Atlanta, GA5 etid
- Dallas, TX5 etid
- Durham, NC5 etid
- Los Angeles, CA4 etid
- Hialeah, FL4 etid
- New York City, NY4 etid
- Boise, ID3 etid
- Baltimore, MD3 etid
- Pittsburgh, PA3 etid
- Chicago, IL3 etid
- Seattle, WA3 etid
- Cincinnati, OH3 etid
- Mountain View, CA3 etid
- Salt Lake City, UT3 etid
- San Francisco, CA3 etid
Pa eta
- Alabama3 etid
- Colorado4 etid
- Distrik Columbia3 etid
- Florid6 etid
- Georgia6 etid
- Idaho3 etid
- Illinois5 etid
- Kalifòni12 etid
- Kentucky3 etid
- Maryland8 etid
- Massachusetts5 etid
- Michigan4 etid
- Minnesota3 etid
- New York6 etid
- North Carolina5 etid
- Ohio7 etid
- Pennsylvania5 etid
- South Carolina3 etid
- Tennessee3 etid
- Texas9 etid
- Utah4 etid
- Virginia4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study of COVID-19 Vaccine(s) in Children and Adults
Ap rekriteFaz 3Volontè an sante akeyi
Laj 5 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06631287Viral Infections in Healthy and Immunocompromised Hosts
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Months – 120 Years · Tout sèks · Mizajou Sep 14, 2026 · NCT01306084Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT04772170Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 40 a 64 · Tout sèks · Mizajou Aug 18, 2026 · NCT06810934Respiratory Virus Sampling and Repository
Ap rekriteEtid obsèvasyon
Laj 3 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05266222A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Aug 7, 2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Jul 23, 2026 · NCT04362150COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Jun 24, 2026 · NCT04391816Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Jun 23, 2026 · NCT03808922Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT01904188Impact of the Coronavirus (COVID-19) on Patients With Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Apr 27, 2026 · NCT04330521ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2026 · NCT04367857A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Ap rekriteFaz 4Volontè an sante akeyi
6 Months · Tout sèks · Mizajou Mar 27, 2026 · NCT06585241Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 9 a 64 · Tout sèks · Mizajou Mar 18, 2026 · NCT04579588Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Ap rekriteEtid obsèvasyon
Laj 7 ak plis · Tout sèks · Mizajou Nov 5, 2025 · NCT04448145Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
Ap rekriteVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Sep 5, 2025 · NCT05868239Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 28, 2021 · NCT04445285Clazakizumab vs. Placebo - COVID-19 Infection
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2020 · NCT04494724Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.